4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-048159
EVP & Chief Commercial Officer sold 7,415 shares at $1.33 ($9,872)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cheng Sohanya Roshan EVP & Chief Commercial Officer | 2023-09-01 | Sale | −7,415 | $1.33 | $9,872 | 204,086 | D: show line 1 in the form |
| Open-market sales · 7,415 sh · avg $1.33 · $9,872 | |||||||
Loading xslF345X05/doc4.xml…